Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Ertapenem

Base Information Edit
  • Chemical Name:Ertapenem
  • CAS No.:153832-46-3
  • Molecular Formula:C22H25N3O7S
  • Molecular Weight:475.522
  • Hs Code.:
  • European Community (EC) Number:836-232-1
  • UNII:G32F6EID2H
  • DSSTox Substance ID:DTXSID50165456
  • Nikkaji Number:J2.766.498I
  • Wikipedia:Ertapenem
  • Wikidata:Q553220
  • NCI Thesaurus Code:C61752
  • RXCUI:325642
  • Metabolomics Workbench ID:42691
  • ChEMBL ID:CHEMBL1359
  • Mol file:153832-46-3.mol
Ertapenem

Synonyms:ertapenem;ertapenem sodium;Invanoz;Invanz

Suppliers and Price of Ertapenem
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Matrix Scientific
  • Ertapenem hydrochloride 95+%
  • 250mg
  • $ 793.00
  • Matrix Scientific
  • Ertapenem hydrochloride 95+%
  • 1g
  • $ 2379.00
  • DC Chemicals
  • Ertapenem >99%
  • 100 mg
  • $ 200.00
  • Crysdot
  • Ertapenem 95+%
  • 1g
  • $ 1995.00
  • Biorbyt Ltd
  • Ertapenem >99%
  • 100 mg
  • $ 414.80
  • Biorbyt Ltd
  • Ertapenem >99%
  • 1 g
  • $ 1208.70
  • Biorbyt Ltd
  • Ertapenem >99%
  • 250 mg
  • $ 615.40
  • AvaChem
  • Ertapenem
  • 1g
  • $ 469.00
  • AvaChem
  • Ertapenem
  • 25mg
  • $ 89.00
  • AvaChem
  • Ertapenem
  • 10mg
  • $ 59.00
Total 139 raw suppliers
Chemical Property of Ertapenem Edit
Chemical Property:
  • Refractive Index:1.7 
  • Boiling Point:813.9 °C at 760 mmHg 
  • PKA:4.03±0.10(Predicted) 
  • Flash Point:446 °C 
  • PSA:181.57000 
  • Density:1.55 g/cm3 
  • LogP:1.28040 
  • Storage Temp.:2-8°C 
  • XLogP3:-1.5
  • Hydrogen Bond Donor Count:5
  • Hydrogen Bond Acceptor Count:9
  • Rotatable Bond Count:7
  • Exact Mass:475.14132132
  • Heavy Atom Count:33
  • Complexity:893
Purity/Quality:

Ertapenem hydrochloride 95+% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Drug Classes:Antiinfective Agents
  • Canonical SMILES:CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O
  • Isomeric SMILES:C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O
  • Recent ClinicalTrials:Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
  • Recent EU Clinical Trials:Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
  • Description Ertapenem is another synthetic carbapenem with a rather complex side chain at C-3. It is used once daily parenterally, with special application against anaerobes. As with meropenem, the 4-β-methyl group confers stability toward dehydropeptidase-1 It is not active against pseudomonads or acinetobacteria and, therefore, should not be substituted for imipenem or meropenem. It is relatively strongly bound to serum proteins, so it has a prolonged half-life, making it more convenient to use than the other carbapenems when its spectrum warrants this. Its reported indications include complicated intra-abdominal and complicated skin/skin structure infections caused by sensitive organisms (for intra-abdominal: Escheri chia coli, Clostri di um clostri doforme, Bacteroi des fragilis, and Peptostreptococcus sp; for skin/skin structures: Staphylococcus aureus (methicillin-susceptible strains), Streptococcus pyogenes, E.coli, or Peptostreptococcus sp.). It can be administered once daily.
  • Uses Ertapenem is a long-acting parenteral cabapenem. Ertapenem has bactericidal activity against a variety of gram-negative pathogens, some gram positive strains, and Haemopilus influenzae. Ertapenem has shown to inactivate L,D-transpeptidase, an enzyme responsible for in vitro cross-linking of Mycobacterium tuberculosis peptidoglycan. Antibacterial. Invanz (Merck).
  • Clinical Use Complicated intra-abdominal infections Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis Community acquired pneumonia Complicated urinary tract infections including pyelonephritis Acute pelvic infections including postpartum endomyometritis, septic abortion and postsurgical gynecologic infections Prophylaxis of surgical site infection following elective colorectal surgery
  • Drug interactions Potentially hazardous interactions with other drugs Antiepileptics: concentration of valproate reduced - avoid concomitant use
Technology Process of Ertapenem

There total 7 articles about Ertapenem which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With 2,6-dimethylpyridine; palladium 10% on activated carbon; hydrogen; sodium acetate; In tetrahydrofuran; water; at 38 - 42 ℃; for 1h; under 15001.5 Torr; Reagent/catalyst;
Guidance literature:
(4-nitrophenyl)methyl (4R,5S,6S)-3-[[(3S,5S)-5-[[(-carboxyphenyl)amino]carbonyl]-1-[[(4-nitrophenyl)methyoxy]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate; With hydrogen; sodium hydrogencarbonate; palladium 10% on activated carbon; In water; acetonitrile; at 0 - 10 ℃; under 4137.29 - 6205.94 Torr;
With hydrogenchloride; In water; acetonitrile; at 5 ℃; pH=5 - 5.4; Product distribution / selectivity;
Post RFQ for Price